MAIAN YE

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology SAN FRANCISCO, CA NPI 1912198110

General Payments — all program years on this page

$5,954.91

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 63
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,838.55 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,820.0715
Education $18.481

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $685.4411
2019 $1,505.0513
2020 $229.782
2021 $18.751
2022 $1,045.8711
2023 $631.479
2024 $1,838.5516

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077939960 Janssen Pharmaceuticals, Inc $128.87 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077940100 Janssen Pharmaceuticals, Inc $149.98 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097613618 Novo Nordisk Inc $125.00 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105766780 AstraZeneca Pharmaceuticals LP $124.99 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112743261 ViiV Healthcare Company $125.00 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115845768 GlaxoSmithKline, LLC. $124.32 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116712355 GlaxoSmithKline, LLC. $79.38 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117420298 Amgen Inc. $18.48 03/13/2024 Education Undisputed 01/23/2026 View at CMS
1117420300 Amgen Inc. $145.62 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117420302 Amgen Inc. $129.41 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120021482 Stryker Corporation $173.45 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135161427 Lilly USA, LLC $98.34 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138838386 Edwards Lifesciences Corporation $88.18 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141513575 CALLIDITAS THERAPEUTICS US INC. $125.38 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141669386 Merck Sharp & Dohme LLC $85.53 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149889142 Travere Therapeutics, Inc. $116.62 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.